Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost — Kaiser Health News

When Michelle Fenner signed up to run this year’s Los Angeles Marathon, it got her thinking: Tijuana, Mexico, is only a 2½-hour drive from L.A. Why not take a trip across the border and buy some insulin for her son? “It’s so easy to just go across the border,” mused Fenner. This idea had been…

via Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost — Kaiser Health News

Advertisements

China Rx

In China Rx, Gibson and Singh discuss China’s long-term strategy to destroy the markets of Western countries in China and take over vital industries.  They cite the expectation of technology transfer held over Western companies who want access to China’s explosive domestic market.  Many Chinese nationals employed by American pharmaceutical firms have stolen trade secrets and provided them to Chinese companies.  Plus, China is heavily involved in cyber-espionage to steal treatment protocols, manufacturing plant specifications, and cost and pricing data to undercut U.S. companies and co-opt government-funded research.

 

It’s not just the carcinogens in your blood pressure medications.  The game is much bigger.

Is Your Generic Medication Made In China and Is It Safe?

Where Are My Generics Medications Made? India, China, or the US?

Statins are more effective for those who follow the Mediterranean diet

Science Daily article here.  Study abstract here.

Conclusions

MD lowered the risk of all-cause, cardiovascular and CAD/cerebrovascular mortality CVD patients, net of statins. In the same population, statins reduced CVD death risk only in combination with MD. Low-grade inflammation, rather than lipids, is likely to be on the pathway of the interaction between MD and statins towards mortality risk.

Nurse Denied Life Insurance Because She Carries Naloxone — Kaiser Health News

Bloodwork was supposed to be the last step in Isela’s application for life insurance. But when she arrived at the lab, her appointment had been canceled. “That was my first warning,” Isela said. She contacted her insurance agent and was told her application was denied because something on her medication list indicated that Isela uses…

via Nurse Denied Life Insurance Because She Carries Naloxone — Kaiser Health News

There are days when I’m so glad I am no longer in a management role.

Today is one of those days.

Counterfeit Prescription Drugs Laced With Fentanyl Falling Into Unsuspecting Hands Thanks In Part To Social Media — Kaiser Health News

People buying drugs like Xanax online are taking the pills, not realizing that they are fake and some are tainted with a potent opioid. The mistake can be fatal. 26 more words

via Counterfeit Prescription Drugs Laced With Fentanyl Falling Into Unsuspecting Hands Thanks In Part To Social Media — Kaiser Health News

Revisiting Who Should Take Aspirin

The Skeptical Cardiologist weighs in on the aspirin debate.
Thank you Dr. Pearson.

The Skeptical Cardiologist

Four years ago the skeptical cardiologist wrote the (in his extremely humble  and biased opinion) the definitive post on aspirin and cardiovascular disease.  Entitled “Should I take aspirin to prevent stroke or heart attack“,  it pointed out that although Dr. Oz had recently told almost all middle-aged women to take a baby aspirin and fish oil, there was, in fact no evidence to support that practice.

The publication of the ASPREE (Aspirin in Reducing Events in the Elderly) trial results in the latest issue of the New England Journal of Medicine further strengthens the points I made in 2014.

Between 2010 and 2014 the ASPREE investigators enrolled over 19,000 community-dwelling persons in Australia and the United States who were 70 years of age or older (or ≥65 years of age among blacks and Hispanics in the United States) and did not have cardiovascular disease, dementia, or disability.

(It’s important…

View original post 1,303 more words

Daily low-dose aspirin found to have no effect on healthy life span in older people

In the total study population, treatment with 100 mg of low-dose aspirin per day did not affect survival free of dementia or disability. Among the people randomly assigned to take aspirin, 90.3 percent remained alive at the end of the treatment without persistent physical disability or dementia, compared with 90.5 percent of those taking a placebo. Rates of physical disability were similar, and rates of dementia were almost identical in both groups.

For the full NIH news release click here.